Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Chem Phys ; 141(5): 051106, 2014 Aug 07.
Article in English | MEDLINE | ID: mdl-25106563

ABSTRACT

We present a low-prefactor, cubically scaling scaled-opposite-spin second-order Møller-Plesset perturbation theory (SOS-MP2) method which is highly suitable for massively parallel architectures like graphics processing units (GPU). The scaling is reduced from O(N5) to O(N³) by a reformulation of the MP2-expression in the atomic orbital basis via Laplace transformation and the resolution-of-the-identity (RI) approximation of the integrals in combination with efficient sparse algebra for the 3-center integral transformation. In contrast to previous works that employ GPUs for post Hartree-Fock calculations, we do not simply employ GPU-based linear algebra libraries to accelerate the conventional algorithm. Instead, our reformulation allows to replace the rate-determining contraction step with a modified J-engine algorithm, that has been proven to be highly efficient on GPUs. Thus, our SOS-MP2 scheme enables us to treat large molecular systems in an accurate and efficient manner on a single GPU-server.


Subject(s)
Computer Graphics , Information Storage and Retrieval/methods , Models, Chemical , Models, Molecular , Quantum Theory , Signal Processing, Computer-Assisted , Software , Algorithms , Computer Simulation , Software Design
2.
J Colloid Interface Sci ; 394: 498-508, 2013 Mar 15.
Article in English | MEDLINE | ID: mdl-23347999

ABSTRACT

The kinetic behavior of aqueous cellulase on insoluble cellulose is best quantified through surface-based assays on a well-defined cellulose substrate of known area. We use a quartz crystal microbalance (QCM) to measure the activity of binary mixtures of Trichoderma longibrachiatum cellobiohydrolase I (Cel7A) and endoglucanase I (Cel7B) on spin-coated cellulose films. By extending a previous surface kinetic model for cellulase activity, we obtain rate constants for competitive adsorption of Cel7A and Cel7B, their irreversible binding, their complexation with the cellulose surface, and their cooperative cellulolytic activity. The activity of the two cellulases is linked through the formation of cellulose chain ends by Cel7B that provide complexation sites from which Cel7A effects cellulose chain scission. Although the rate-limiting step in Cel7A activity is complexation, Cel7B activity is limited by adsorption to the cellulose surface. A 2:1 bulk mass ratio of aqueous Cel7A:Cel7B, corresponding to a 4:1 surface mass ratio, effects the greatest rate of cellulose degradation across a range of cellulase concentrations at 25 °C. We find that surface chain-end concentration is a major predictor of Cel7A activity. Disruption of the hydrogen-bonding structure of cellulose by Cel7B enhances the activity of Cel7A on the cellulose surface.


Subject(s)
Cellulose 1,4-beta-Cellobiosidase/metabolism , Cellulose/metabolism , Trichoderma/enzymology , Kinetics , Quartz Crystal Microbalance Techniques
3.
Pharmacol Biochem Behav ; 51(2-3): 345-51, 1995.
Article in English | MEDLINE | ID: mdl-7667351

ABSTRACT

Excitatory amino acid antagonists (EAAAs) have been shown to disrupt learning and memory in a variety of cognitive tasks. EAAAs have been reported to produce differential effects on working memory (WM) and reference memory (RM) or to have no effect at all. Apparent selective effects of EAAAs on WM and/or RM may have been due to differences between the effects of competitive and noncompetitive EAAAs, dose selection, or to different task requirements for the WM and RM components. In the present experiments, we assessed the effects of a noncompetitive EAAA (MK-801), a competitive EAAA (CPP), and the muscarinic antagonist scopolamine in two cognitive tasks, the split-stem T-maze and the eight-arm radial maze. In these two tasks, the WM and the RM components differed in their relative degree of difficulty. Gerbils were trained on either the T-maze, where WM was more difficult than RM, or on the radial arm maze, where RM was more difficult than WM. In the T-maze, MK-801 (0.1 mg/kg, IP, 30 min prior), CPP (30.0 mg/kg, IP, 2 h prior) and scopolamine (0.3 mg/kg, IP, 30 min prior) impaired both WM and RM, but the magnitude of the impairing effect was statistically greater for the WM component, the more difficult of the two components. Lower doses of these three compounds produced either selective effects on WM or no effect at all. In the radial arm maze all three drugs impaired both components, but the magnitude of the impairing effect was statistically greater for the RM component, the more difficult of the two components.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Excitatory Amino Acid Antagonists/pharmacology , Memory, Short-Term/drug effects , Memory/drug effects , Animals , Cognition/drug effects , Dizocilpine Maleate/pharmacology , Dose-Response Relationship, Drug , Female , Gerbillinae , Maze Learning/drug effects , Piperazines/pharmacology , Scopolamine/pharmacology
4.
Obstet Gynecol ; 78(1): 98-102, 1991 Jul.
Article in English | MEDLINE | ID: mdl-1904568

ABSTRACT

A prospective study was performed in 24 premenopausal women to evaluate the gonadotropin dynamics of pharmacologic doses of transdermal estradiol-17 beta (E2) administered after bilateral oophorectomy. Patients were given 0.2-mg transdermal E2 patches for 2 weeks, followed by 0.1-mg patches for 4 weeks either immediately postoperatively (immediate estrogen replacement therapy [ERT]) or beginning 12-14 days after surgery (delayed ERT). Serum gonadotropins and E2 levels were measured serially, and postmenopausal symptoms were prospectively recorded. Administration of 0.2 mg transdermal E2 immediately after surgery suppressed the post-castration rise in gonadotropins for at least 4 days, but LH and FSH levels did increase to the menopausal range after 2 weeks despite continued therapy. Sustained circulating levels of E2 with transdermal E2 therapy were comparable to follicular phase values. Vasomotor symptoms were well controlled by 0.2 mg of transdermal E2 in the majority of patients during the clinical trial. There was no significant estrogen-related morbidity despite the large doses used. Two patients had skin irritation at the patch site causing discontinuation of therapy. These data suggest that large doses of transdermal E2 can suppress gonadotropin levels only for a brief interval. We were unable to demonstrate any long-term alteration in the hypothalamic-pituitary set point for sensitivity to exogenous E2.


Subject(s)
Estradiol/pharmacology , Estrogen Replacement Therapy , Follicle Stimulating Hormone/blood , Luteinizing Hormone/blood , Ovariectomy , Postoperative Care/methods , Administration, Cutaneous , Adult , Estradiol/administration & dosage , Estradiol/blood , Estradiol/therapeutic use , Female , Humans , Middle Aged , Prospective Studies , Time Factors
5.
J Dairy Sci ; 72(6): 1451-8, 1989 Jun.
Article in English | MEDLINE | ID: mdl-2760307

ABSTRACT

Bovine plasma and lipoproteins isolated by gel filtration chromatography were examined for their ability to activate skim milk lipoprotein lipase. Addition of equal amounts of protein from either triglyceride-rich lipoprotein, low density lipoprotein, high density lipoprotein or plasma to a lipoprotein lipase assay resulted in 6.0, 2.2, 2.5, or 1.1% hydrolysis of radiolabelled triglyceride emulsion. Lipoprotein lipase activity in skim milk was evaluated as an indicator of mammary lipid secretory capacity. Skim milk lipoprotein lipase activity was significantly lower immediately prepartum as compared with activity immediately postpartum (.2 vs. 5.4% of substrate hydrolyzed). Skim milk lipoprotein lipase was significantly higher during the final 12 d of lactation than in samples obtained 12 d after machine milking was terminated (5.6 vs. less than 1% of substrate hydrolyzed). Although skim milk lipoprotein lipase activity appeared positively related to mammary lipid secretory capacity during the time immediately surrounding initiation and cessation of copious milk production, activity between those periods was not correlated to milk fat percentage, milk fat yield, or stage of lactation.


Subject(s)
Cattle/metabolism , Lipids/biosynthesis , Lipoprotein Lipase/metabolism , Lipoproteins/pharmacology , Mammary Glands, Animal/metabolism , Milk/enzymology , Animals , Enzyme Activation , Female , Lipoproteins/metabolism , Lipoproteins, HDL/metabolism , Lipoproteins, HDL/pharmacology , Lipoproteins, LDL/metabolism , Lipoproteins, LDL/pharmacology , Mammary Glands, Animal/cytology , Triglycerides/metabolism
6.
J Fam Pract ; 9(2): 237-40, 1979 Aug.
Article in English | MEDLINE | ID: mdl-458391

ABSTRACT

A case is reported of apparent podophyllum toxicity. The patient was a 17-year-old female Indian who had received some 3 to 8 cc of a 20 percent mixture of podophyllum resin in compound tincture of benzoin (approximately equal to 0.4 gm of podophylotoxin) as an application to her vulvar condylomata. She returned to the hospital 20 hours after application in a comatose state. On examination she demonstrated severe toxicity including bone marrow, liver, and central nervous system. She required a charcoal hemoperfusion at the University of Colorado, and six months after the event has several neurologic and physiologic sequelae. Podophyllum is a potentially severely toxic drug. Great care must be taken when treating patients with this drug. A large mass of condylomata or the status of pregnancy should be relative contraindications to the use of podophyllum.


Subject(s)
Condylomata Acuminata/drug therapy , Hemoperfusion , Podophyllin/toxicity , Vulvar Neoplasms/drug therapy , Adolescent , Female , Humans , Malabsorption Syndromes/chemically induced , Podophyllin/therapeutic use , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...